BlackRock
HCWB icon

BlackRock’s HCW Biologics HCWB Stock Holding History

BlackRock’s Portfolio HCWB Stock Details HCWB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-176
Closed -$11.9K – 5513
2025
Q1 		$11.9K Sell
176
-3
-2% -$264 ﹤0.01% 5163
2024
Q4 		$19.2K Sell
179
-6
-3% -$700 ﹤0.01% 5110
2024
Q3 		$23.9K Buy
185
+7
+4% +$954 ﹤0.01% 4916
2024
Q2 		$27.6K Sell
178
-14
-7% -$4.14K ﹤0.01% 4960
2024
Q1 		$80.6K Sell
192
-4
-2% -$1.28K ﹤0.01% 4783
2023
Q4 		$57.8K Sell
196
-3
-2% -$1.02K ﹤0.01% 4941
2023
Q3 		$90.7K Sell
199
-8
-4% -$3.96K ﹤0.01% 4874
2023
Q2 		$108K Buy
207
+23
+13% +$9.15K ﹤0.01% 4889
2023
Q1 		$61.7K Buy
184
+6
+3% +$2.6K ﹤0.01% 5077
2022
Q4 		$81.7K Buy
178
+4
+2% +$2.07K ﹤0.01% 5102
2022
Q3 		$96K Sell
174
-5
-3% -$2.87K ﹤0.01% 5186
2022
Q2 		$94K Buy
179
+14
+8% +$7.86K ﹤0.01% 5258
2022
Q1 		$108K Buy
165
+95
+136% +$50.7K ﹤0.01% 5270
2021
Q4 		$39K Buy
70
+2
+3% +$1.36K ﹤0.01% 5446
2021
Q3 		$52K Buy
+68
New +$71.5K ﹤0.01% 5277

Other funds holding HCWB

GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

BlackRock's HCWB Position: Q2 2025 in Review

BlackRock sold out of HCW Biologics (HCWB) in Q2 2025, closing a stake of 176 shares — an estimated $11.9K sold.

BlackRock first reported a position in HCWB in Q3 2021 and held it in 15 quarters. The position peaked at $108K in Q1 2022. 8 funds tracked by Wall St. Rank hold HCWB as of Q2 2025.

  • BlackRock reported no remaining HCW Biologics position as of Q2 2025 after selling out during the quarter.
  • BlackRock sold 176 HCW Biologics shares in Q2 2025, an estimated $11.9K.
  • BlackRock first reported a position in HCW Biologics in Q3 2021 and held it in 15 quarters.
  • BlackRock's HCW Biologics position peaked at $108K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held HCW Biologics as of Q2 2025.

Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.